Airsculpt Technologies Inc (AIRS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Airsculpt Technologies Inc stock (AIRS) is currently trading at $2.82. Airsculpt Technologies Inc PS ratio (Price-to-Sales) is 1.05. Analyst consensus price target for AIRS is $6.00. WallStSmart rates AIRS as Sell.
- AIRS PE ratio analysis and historical PE chart
- AIRS PS ratio (Price-to-Sales) history and trend
- AIRS intrinsic value — DCF, Graham Number, EPV models
- AIRS stock price prediction 2025 2026 2027 2028 2029 2030
- AIRS fair value vs current price
- AIRS insider transactions and insider buying
- Is AIRS undervalued or overvalued?
- Airsculpt Technologies Inc financial analysis — revenue, earnings, cash flow
- AIRS Piotroski F-Score and Altman Z-Score
- AIRS analyst price target and Smart Rating
Airsculpt Technologies Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Airsculpt Technologies Inc (AIRS) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, eps growth. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Airsculpt Technologies Inc (AIRS) Key Strengths (4)
Earnings per share surging 200.00% year-over-year
76.34% of shares held by major funds and institutions
Paying $1.05 for every $1 of annual revenue
Trading at 2.00x book value, attractively priced
Supporting Valuation Data
Airsculpt Technologies Inc (AIRS) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Revenue declining -17.80%, a shrinking business
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Airsculpt Technologies Inc (AIRS) Detailed Analysis Report
Overall Assessment
This company scores 40/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 4 register as strengths (avg 9.0/10) while 5 fall into concern territory (avg 0.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on EPS Growth, Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.05), Price/Book (2.00) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 200.00%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -17.80%, which may limit upside. Profitability pressure is visible in Return on Equity at -21.80%, Operating Margin at -7.47%, Profit Margin at -11.40%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -21.80% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -17.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AIRS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AIRS's Price-to-Sales ratio of 1.05x trades at a deep discount to its historical average of 2.54x (16th percentile). The current valuation is 91% below its historical high of 11.99x set in Nov 2021, and 91% above its historical low of 0.55x in Feb 2026. Over the past 12 months, the PS ratio has expanded from ~0.8x, reflecting growing market expectations outpacing revenue growth.
Compare AIRS with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Airsculpt Technologies Inc (AIRS) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
Airsculpt Technologies Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 158M with 18% decline year-over-year. The company is currently unprofitable, posting a -11.4% profit margin.
Key Findings
Revenue contracted 18% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -11.4% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Volatility is elevated with a beta of 2.80, so expect amplified moves relative to the broader market.
Debt management: total debt of 84M is significantly higher than cash (5M). Monitor refinancing risk.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Airsculpt Technologies Inc.
Bottom Line
Airsculpt Technologies Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(12 last 3 months)
| Insider | Type | Shares |
|---|---|---|
CHERNETT, JOREY 10% Owner | Buy | +40,000 |
| Insider | Type | Shares |
|---|---|---|
CHERNETT, JOREY 10% Owner | Buy | +77,702 |
| Insider | Type | Shares |
|---|---|---|
JASHNANI, YOGESH Director, Chief Executive Officer | Sell | -38,379 |
| Insider | Type | Shares |
|---|---|---|
CHERNETT, JOREY 10% Owner | Buy | +83,000 |
| Insider | Type | Shares |
|---|---|---|
CHERNETT, JOREY 10% Owner | Buy | +105,848 |
| Insider | Type | Shares |
|---|---|---|
CHERNETT, JOREY 10% Owner | Buy | +88,000 |
| Insider | Type | Shares |
|---|---|---|
CHERNETT, JOREY 10% Owner | Buy | +45,600 |
| Insider | Type | Shares |
|---|---|---|
CHERNETT, JOREY 10% Owner | Buy | +30,000 |
| Insider | Type | Shares |
|---|---|---|
CHERNETT, JOREY 10% Owner | Buy | +80,000 |
| Insider | Type | Shares |
|---|---|---|
JASHNANI, YOGESH Director, Chief Executive Officer | Sell | -24,217 |
Data sourced from SEC Form 4 filings
Last updated: 8:24:19 AM
About Airsculpt Technologies Inc(AIRS)
NASDAQ
HEALTHCARE
MEDICAL CARE FACILITIES
USA
Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, renowned for its innovative AirSculpt® procedure, which provides minimally invasive body contouring solutions. The company prioritizes patient safety and comfort while delivering remarkable aesthetic outcomes, thereby transforming the cosmetic surgery experience. With a robust network of licensed practitioners and a strong commitment to technological advancement, Airsculpt is strategically positioned to capitalize on the increasing global demand for non-invasive cosmetic procedures, aiming to enhance its market presence and diversify its offerings. This proactive approach not only drives immediate growth but also sets the foundation for sustainable long-term value creation for its investors.